• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.55% Nasdaq Down 0.85%

    Cytosorbents Corporation (CTSO)

    -OTC BB
    4.34 Down 0.16(3.56%) 3:13PM EDT - Nasdaq Real Time Price
    Prev Close:4.50
    Open:4.53
    Bid:4.31 x 5100
    Ask:4.36 x 200
    1y Target Est:21.38
    Beta:-0.524075
    Earnings Date:May 9 - May 13 (Est.)
    Day's Range:4.21 - 4.53
    52wk Range:3.11 - 8.19
    Volume:46,951
    Avg Vol (3m):75,098
    Market Cap:110.26M
    P/E (ttm):N/A
    EPS (ttm):-0.69
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CTSODown 3.56%110.26M
    LLYDown 1.45%79.51B
    BAXDown 0.53%24.22B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):29.24
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.39
    Quarterly EPS Est (Mar-16) :-0.10
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CytoSorbents Corporation, a critical care focused immunotherapy company, engages in the research, development, and commercialization of medical devices with its platform blood purification technology incorporating a proprietary adsorbent polymer t... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback